JMD Stock Overview
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Japan Medical Dynamic Marketing, INC. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3.96 |
| 52 Week High | JP¥6.85 |
| 52 Week Low | JP¥3.90 |
| Beta | 0.42 |
| 1 Month Change | -11.21% |
| 3 Month Change | -16.10% |
| 1 Year Change | -40.90% |
| 3 Year Change | -75.25% |
| 5 Year Change | -58.75% |
| Change since IPO | -10.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| JMD | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.0% | 3.7% | -2.0% |
| 1Y | -40.9% | -3.9% | -0.3% |
Return vs Industry: JMD underperformed the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: JMD underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| JMD volatility | |
|---|---|
| JMD Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: JMD has not had significant price volatility in the past 3 months.
Volatility Over Time: JMD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 488 | Toshiyuki Hironaka | www.jmdm.co.jp |
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects.
Japan Medical Dynamic Marketing, INC. Fundamentals Summary
| JMD fundamental statistics | |
|---|---|
| Market cap | €107.46m |
| Earnings (TTM) | €6.17m |
| Revenue (TTM) | €137.49m |
17.4x
P/E Ratio0.8x
P/S RatioIs JMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JMD income statement (TTM) | |
|---|---|
| Revenue | JP¥22.68b |
| Cost of Revenue | JP¥8.10b |
| Gross Profit | JP¥14.57b |
| Other Expenses | JP¥13.56b |
| Earnings | JP¥1.02b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 38.62 |
| Gross Margin | 64.27% |
| Net Profit Margin | 4.48% |
| Debt/Equity Ratio | 7.6% |
How did JMD perform over the long term?
See historical performance and comparison